Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Liabilities: 2017-2025

Historic Total Liabilities for Rockwell Medical (RMTI) over the last 8 years, with Sep 2025 value amounting to $20.5 million.

  • Rockwell Medical's Total Liabilities fell 26.77% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year decrease of 26.77%. This contributed to the annual value of $26.6 million for FY2024, which is 13.79% down from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Total Liabilities is $20.5 million, which was down 7.88% from $22.2 million recorded in Q2 2025.
  • Rockwell Medical's Total Liabilities' 5-year high stood at $47.6 million during Q3 2021, with a 5-year trough of $20.5 million in Q3 2025.
  • Moreover, its 3-year median value for Total Liabilities was $27.9 million (2024), whereas its average is $27.1 million.
  • As far as peak fluctuations go, Rockwell Medical's Total Liabilities climbed by 10.30% in 2021, and later tumbled by 33.88% in 2023.
  • Quarterly analysis of 5 years shows Rockwell Medical's Total Liabilities stood at $46.0 million in 2021, then declined by 29.34% to $32.5 million in 2022, then fell by 5.06% to $30.9 million in 2023, then dropped by 13.79% to $26.6 million in 2024, then fell by 26.77% to $20.5 million in 2025.
  • Its last three reported values are $20.5 million in Q3 2025, $22.2 million for Q2 2025, and $22.4 million during Q1 2025.